Afuco™ Anti-Human VEGFC ADCC Recombinant Antibody (VGX100), ADCC Enhanced
CAT#: AFC-635CL
Anti-VEGFC ADCC Enhanced Antibody (VGX100) is an ADCC enhanced antibody produced by our Afuco™ platform. VGX-100 is a human antibody that acts against the human vascular endothelial growth factor (VEGF)-C protein. Treatment for cancers, particularly glioblastoma and metastatic colorectal cancers, are the first target indications for VGX-100. Additionally, VGX-100 is developing for a number of other cancer indications, and as an agent to treat front-of the-eye diseases.

Specifications
- Host Species
- Human
- Derivation
- Human
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Applications
- Neut, FuncS
- Related Disease
- Glioma; Prostate Cancer; Solid Tumors
Product Property
- Purity
- >97%, by SDS-PAGE under reducing conditions
- Storage
- Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Applications
- Application Notes
- VEGF-C Neutralization with Blocking Antibody
VEGF-C was blocked using neutralizing monoclonal anti-VEGF-C (VGX-100). VGX-100 was commercially supplied, based on a signed material transfer agreement; and according to the manufacturer, VGX-100 binds to and precipitates all forms of VEGF-C including full-length, partially processed, and mature forms in both the human and mouse. To block VEGF-C, 20 mg/kg (in total 0.1 mL volume) of VGX-100 was injected from the day before surgery, through the intraperitoneal route and on alternate days subsequently up to 2 weeks. Control mice received 0.1 mL of normal saline intraperitoneally.
Target
Customer Review
There are currently no Customer reviews or questions for AFC-635CL. Click the button above to contact us or submit your feedback about this product.



Q&As
-
What specific laboratory assays can be used to verify the ADCC enhancement of Afuco™ Anti-Human VEGFC ADCC Recombinant Antibody (VGX100)?
A: ADCC enhancement for VGX100 can be verified through various assays such as the Chromium Release Assay, where target cells are labeled with chromium-51 and the lysis of these cells by effector cells in the presence of VGX100 is measured. Additionally, flow cytometry-based cytotoxicity assays and ELISA for cytokine release can also provide evidence of ADCC activity.
-
How does this Antibody (VGX100) influence angiogenesis in tumor environments?
A: VGX100 targets VEGFC to inhibit its function, which is crucial for angiogenesis in tumor environments. By blocking VEGFC, VGX100 effectively reduces the formation of new blood vessels that supply nutrients and oxygen to the tumor, thereby inhibiting tumor growth and metastasis.
-
How does the ADCC Enhanced antibody differ from traditional anti-VEGFC antibodies in terms of activation of the immune response?
A: Afuco™ Anti-Human VEGFC ADCC Recombinant Antibody (VGX100), ADCC Enhanced is specifically engineered for ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) enhancement. Unlike traditional anti-VEGFC antibodies, VGX100 not only neutralizes VEGFC but also optimizes the Fc region to more effectively engage immune effector cells, leading to an amplified and targeted immune response against VEGFC-expressing cells.
View the frequently asked questions answered by Creative Biolabs Support.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Related Signaling Pathways
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
See other products for "VEGFC"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1722z | Mouse Anti-VEGFC Recombinant Antibody (clone 10F5) | WB, ICC, IF, IHC | Mouse IgG2a |
MOB-0226MC | Anti-Human VEGF-C Antibody | WB, ICC, IF, IHC, IHC-P | |
MOB-2183MZ | Recombinant Mouse Anti-Human VEGFC Antibody (clone 0/F8) | IHC-Fr, WB | Mouse antibody |
VS3-QX1233 | Mouse Anti-VEGFC Recombinant Antibody (clone 2E2-F8-C6) | WB | |
VS3-CJ994 | Mouse Anti-VEGFC Recombinant Antibody (VS3-CJ994) | WB | Mouse IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-661CL | Human Anti-VEGFC Recombinant Antibody (TAB-661CL) | ELISA | Human IgG |
TAB-311CQ | Human Anti-VEGFC Recombinant Antibody (TAB-311CQ) | ELISA, WB | Human IgG |
TAB-311CQ-S(P) | Human Anti-VEGFC Recombinant Antibody (TAB-311CQ-S(P)); scFv Fragment | ELISA, WB, Neut | Human scFv |
TAB-311CQ-F(E) | Human Anti-VEGFC Recombinant Antibody (TAB-311CQ-F(E)); Fab Fragment | ELISA, WB, Neut | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-309CQ | Human Anti-VEGFC Recombinant Antibody (TAB-309CQ) | Block, ELISA, FuncS | Humanized antibody |
TAB-309CQ-S(P) | Human Anti-VEGFC Recombinant Antibody; scFv Fragment (TAB-309CQ-S(P)) | ELISA, FC, WB, BL | Humanized scFv |
TAB-309CQ-F(E) | Human Anti-VEGFC Recombinant Antibody; Fab Fragment (TAB-309CQ-F(E)) | ELISA, FC, WB, BL | Humanized Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-310CQ | Mouse Anti-VEGFC Recombinant Antibody (TAB-310CQ) | Block, ELISA, FuncS | Mouse IgG2a, κ |
TAB-310CQ-S(P) | Mouse Anti-VEGFC Recombinant Antibody; scFv Fragment (TAB-310CQ-S(P)) | ELISA, FC, WB, BL | Mouse scFv |
TAB-310CQ-F(E) | Mouse Anti-VEGFC Recombinant Antibody; Fab Fragment (TAB-310CQ-F(E)) | ELISA, FC, WB, BL | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
VS-0325-XY2468 | Anti-VEGFC Immunohistochemistry Kit | IHC | |
VS-0525-XY7842 | Anti-Mouse VEGFC Immunohistochemistry Kit | IHC | |
VS-0525-XY7841 | Anti-Human VEGFC Immunohistochemistry Kit | IHC |
Popular Products
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: Neut, ELISA, FuncS
Application: WB, IF, FuncS
Application: WB, ELISA, IF
Application: WB, ELISA, FC, IHC, IF, IP
Application: ELISA, IF, Block, FuncS
Application: IF, IP, Neut, FuncS, ELISA, FC
Application: ELISA, IHC, WB
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.